APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Acinetobacter Infections Treatment

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

Selected research

Market Structure

Global Acinetobacter Infections Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17395980032 January 2026192 pages

Choose your research edition.

Industry ResearchAcinetobacter Infections Treatment Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Acinetobacter Infections Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Acinetobacter Infections Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acinetobacter Infections Treatment Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Acinetobacter Infections Treatment Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.

Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.

Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.

Read the full market overview

In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.

Report Includes

This report provides an overview of the global Acinetobacter Infections Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Acinetobacter Infections Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Acinetobacter Infections Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Acinetobacter Infections Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Acinetobacter Infections Treatment Segment by Company

Entasis Therapeutics

Roche

Adenium Biotech

Vaxdyn

Hsiri Therapeutics

Aridis Pharmaceuticals

LegoChem Biosciences

Atterx Biotherapeutics

Achaogen

Peptilogics

Sealife PHARMA

Shionogi

Techulon

Tetraphase Pharmaceuticals

Acinetobacter Infections Treatment Segment by Type

Sulbactam

Carbapenems

Aminoglycosides

Polymyxins

Tetracyclines

Others

Acinetobacter Infections Treatment Segment by Pipeline

ETX2514

Nacubactam RG6080

Arenicin

VXD-001

Small Molecule Antibiotic

AR-401 mAB

LCB01-0371 (PO)

GN-4474

Antibacterial Antibody

Others

Acinetobacter Infections Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acinetobacter Infections Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acinetobacter Infections Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acinetobacter Infections Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Acinetobacter Infections Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Acinetobacter Infections Treatment industry.

Chapter 3: Detailed analysis of Acinetobacter Infections Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acinetobacter Infections Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Sulbactam Table 3. Key Players of Carbapenems Table 4. Key Players of Aminoglycosides Table 3. Key Players of Polymyxins Table 4. Key Players of Tetracyclines Table 5. Key Players of Others Table 6. Global Acinetobacter Infections Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 7. Key Players of ETX2514 Table 8. Key Players of Nacubactam RG6080 Table 9. Key Players of Arenicin Table 10. Key Players of VXD-001 Table 11. Key Players of Small Molecule Antibiotic Table 12. Key Players of AR-401 mAB Table 13. Key Players of LCB01-0371 (PO) Table 14. Key Players of GN-4474 Table 15. Key Players of Antibacterial Antibody Table 16. Key Players of Others Table 17. Global Acinetobacter Infections Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Acinetobacter Infections Treatment Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Acinetobacter Infections Treatment Market Share by Region (2021-2026) Table 20. Global Acinetobacter Infections Treatment Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Acinetobacter Infections Treatment Market Share by Region (2027-2032) Table 22. Acinetobacter Infections Treatment Industry Trends Table 23. Acinetobacter Infections Treatment Industry Drivers Table 24. Acinetobacter Infections Treatment Industry Opportunities and Challenges Table 25. Acinetobacter Infections Treatment Industry Restraints Table 26. Global Acinetobacter Infections Treatment Revenue by Company (US$ Million) & (2021-2026) Table 27. Global Acinetobacter Infections Treatment Revenue Market Share by Company (2021-2026) Table 28. Global Acinetobacter Infections Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 29. Global Acinetobacter Infections Treatment Key Company Head Office and Area Served Table 30. Global Acinetobacter Infections Treatment Company, Product Type & Application Table 31. Global Acinetobacter Infections Treatment Company Establishment Date Table 32. Global Company Market Concentration Ratio (CR5 and HHI) Table 33. Global Acinetobacter Infections Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 34. Global Acinetobacter Infections Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Acinetobacter Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 36. Global Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 37. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2021-2026) Table 38. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2027-2032) Table 39. Global Acinetobacter Infections Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Acinetobacter Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 41. Global Acinetobacter Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 42. Global Acinetobacter Infections Treatment Revenue Market Share by Application (2021-2026) Table 43. Global Acinetobacter Infections Treatment Revenue Market Share by Application (2027-2032) Table 44. Entasis Therapeutics Company Information Table 45. Entasis Therapeutics Business Overview Table 46. Entasis Therapeutics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Entasis Therapeutics Acinetobacter Infections Treatment Product Portfolio Table 48. Entasis Therapeutics Recent Development Table 49. Roche Company Information Table 50. Roche Business Overview Table 51. Roche Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Roche Acinetobacter Infections Treatment Product Portfolio Table 53. Roche Recent Development Table 54. Adenium Biotech Company Information Table 55. Adenium Biotech Business Overview Table 56. Adenium Biotech Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Adenium Biotech Acinetobacter Infections Treatment Product Portfolio Table 58. Adenium Biotech Recent Development Table 59. Vaxdyn Company Information Table 60. Vaxdyn Business Overview Table 61. Vaxdyn Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Vaxdyn Acinetobacter Infections Treatment Product Portfolio Table 63. Vaxdyn Recent Development Table 64. Hsiri Therapeutics Company Information Table 65. Hsiri Therapeutics Business Overview Table 66. Hsiri Therapeutics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Hsiri Therapeutics Acinetobacter Infections Treatment Product Portfolio Table 68. Hsiri Therapeutics Recent Development Table 69. Aridis Pharmaceuticals Company Information Table 70. Aridis Pharmaceuticals Business Overview Table 71. Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio Table 73. Aridis Pharmaceuticals Recent Development Table 74. LegoChem Biosciences Company Information Table 75. LegoChem Biosciences Business Overview Table 76. LegoChem Biosciences Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. LegoChem Biosciences Acinetobacter Infections Treatment Product Portfolio Table 78. LegoChem Biosciences Recent Development Table 79. Atterx Biotherapeutics Company Information Table 80. Atterx Biotherapeutics Business Overview Table 81. Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Atterx Biotherapeutics Acinetobacter Infections Treatment Product Portfolio Table 83. Atterx Biotherapeutics Recent Development Table 84. Achaogen Company Information Table 85. Achaogen Business Overview Table 86. Achaogen Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Achaogen Acinetobacter Infections Treatment Product Portfolio Table 88. Achaogen Recent Development Table 89. Peptilogics Company Information Table 90. Peptilogics Business Overview Table 91. Peptilogics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. Peptilogics Acinetobacter Infections Treatment Product Portfolio Table 93. Peptilogics Recent Development Table 94. Sealife PHARMA Company Information Table 95. Sealife PHARMA Business Overview Table 96. Sealife PHARMA Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Sealife PHARMA Acinetobacter Infections Treatment Product Portfolio Table 98. Sealife PHARMA Recent Development Table 99. Shionogi Company Information Table 100. Shionogi Business Overview Table 101. Shionogi Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Shionogi Acinetobacter Infections Treatment Product Portfolio Table 103. Shionogi Recent Development Table 104. Techulon Company Information Table 105. Techulon Business Overview Table 106. Techulon Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. Techulon Acinetobacter Infections Treatment Product Portfolio Table 108. Techulon Recent Development Table 109. Tetraphase Pharmaceuticals Company Information Table 110. Tetraphase Pharmaceuticals Business Overview Table 111. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio Table 113. Tetraphase Pharmaceuticals Recent Development Table 114. North America Acinetobacter Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 115. North America Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 116. North America Acinetobacter Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 117. North America Acinetobacter Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 118. North America Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America Acinetobacter Infections Treatment Market Size by Country (2021-2026) Table 120. North America Acinetobacter Infections Treatment Market Size by Country (2027-2032) Table 121. Europe Acinetobacter Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 122. Europe Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 123. Europe Acinetobacter Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 124. Europe Acinetobacter Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 125. Europe Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Europe Acinetobacter Infections Treatment Market Size by Country (2021-2026) Table 127. Europe Acinetobacter Infections Treatment Market Size by Country (2027-2032) Table 128. China Acinetobacter Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 129. China Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 130. China Acinetobacter Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 131. China Acinetobacter Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Acinetobacter Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 133. Asia Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 134. Asia Acinetobacter Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 135. Asia Acinetobacter Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 136. Asia Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Asia Acinetobacter Infections Treatment Market Size by Country (2021-2026) Table 138. Asia Acinetobacter Infections Treatment Market Size by Country (2027-2032) Table 139. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2021-2026) & (US$ Million) Table 140. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2027-2032) & (US$ Million) Table 141. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Application (2021-2026) & (US$ Million) Table 142. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Application (2027-2032) & (US$ Million) Table 143. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2021-2026) Table 145. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2027-2032) Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Acinetobacter Infections Treatment Product Image Figure 2. Global Acinetobacter Infections Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Acinetobacter Infections Treatment Market Share by Type: 2025 VS 2032 Figure 4. Sulbactam Image Figure 5. Carbapenems Image Figure 6. Aminoglycosides Image Figure 7. Polymyxins Image Figure 8. Tetracyclines Image Figure 9. Others Image Figure 10. Global Acinetobacter Infections Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 11. Global Acinetobacter Infections Treatment Market Share by Application: 2025 VS 2032 Figure 12. ETX2514 Image Figure 13. Nacubactam RG6080 Image Figure 14. Arenicin Image Figure 15. VXD-001 Image Figure 16. Small Molecule Antibiotic Image Figure 17. AR-401 mAB Image Figure 18. LCB01-0371 (PO) Image Figure 19. GN-4474 Image Figure 20. Antibacterial Antibody Image Figure 21. Others Image Figure 22. Global Acinetobacter Infections Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 23. Global Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 24. Global Acinetobacter Infections Treatment Market Share by Region: 2025 VS 2032 Figure 25. Years Considered Figure 26. Global Acinetobacter Infections Treatment Market Share by Players in 2025 Figure 27. Global Top 5 and 10 Acinetobacter Infections Treatment Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Acinetobacter Infections Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2021-2032) Figure 31. Global Acinetobacter Infections Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Acinetobacter Infections Treatment Revenue Market Share by Application (2021-2032) Figure 33. North America Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 34. North America Acinetobacter Infections Treatment Market Share by Type (2021-2032) Figure 35. North America Acinetobacter Infections Treatment Market Share by Application (2021-2032) Figure 36. North America Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 37. United States Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Canada Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Mexico Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 40. Europe Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 41. Europe Acinetobacter Infections Treatment Market Share by Type (2021-2032) Figure 42. Europe Acinetobacter Infections Treatment Market Share by Application (2021-2032) Figure 43. Europe Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 44. Germany Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 45. France Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 46. U.K. Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 47. Italy Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 48. Russia Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Nordic Countries Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 50. China Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 51. China Acinetobacter Infections Treatment Market Share by Type (2021-2032) Figure 52. China Acinetobacter Infections Treatment Market Share by Application (2021-2032) Figure 53. Asia Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 54. Asia Acinetobacter Infections Treatment Market Share by Type (2021-2032) Figure 55. Asia Acinetobacter Infections Treatment Market Share by Application (2021-2032) Figure 56. Asia Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 57. Japan Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Korea Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Taiwan Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Southeast Asia Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 61. India Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 62. Australia Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 63. South America, Middle East & Africa Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 64. South America, Middle East & Africa Acinetobacter Infections Treatment Market Share by Type (2021-2032) Figure 65. South America, Middle East & Africa Acinetobacter Infections Treatment Market Share by Application (2021-2032) Figure 66. South America, Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2021-2032) Figure 67. Brazil Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 68. South Africa Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 69. Saudi Arabia Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 70. Turkey Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 71. Argentina Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 72. UAE Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 73. Egypt Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 74. Chile Acinetobacter Infections Treatment Market Size (2021-2032) & (US$ Million) Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Sulbactam
  • Carbapenems
  • Aminoglycosides
  • Polymyxins
  • Tetracyclines
  • Others
Applications
  • ETX2514
  • Nacubactam RG6080
  • Arenicin
  • VXD-001
  • Small Molecule Antibiotic
  • AR-401 mAB
  • LCB01-0371 (PO)
  • GN-4474
  • Antibacterial Antibody
  • Others
Companies covered
  • Entasis Therapeutics
  • Roche
  • Adenium Biotech
  • Vaxdyn
  • Hsiri Therapeutics
  • Aridis Pharmaceuticals
  • LegoChem Biosciences
  • Atterx Biotherapeutics
  • Achaogen
  • Peptilogics
  • Sealife PHARMA
  • Shionogi
  • Techulon
  • Tetraphase Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Sulbactam
  5. 1.2.3 Carbapenems
  6. 1.2.4 Aminoglycosides
  7. 1.2.5 Polymyxins
  8. 1.2.6 Tetracyclines
  9. 1.2.7 Others
  10. 1.3 Market Analysis by Application
  11. 1.3.1 Global Acinetobacter Infections Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  12. 1.3.2 ETX2514
  13. 1.3.3 Nacubactam RG6080
  14. 1.3.4 Arenicin
  15. 1.3.5 VXD-001
  16. 1.3.6 Small Molecule Antibiotic
  17. 1.3.7 AR-401 mAB
  18. 1.3.8 LCB01-0371 (PO)
  19. 1.3.9 GN-4474
  20. 1.3.10 Antibacterial Antibody
  21. 1.3.11 Others
  22. 1.4 Global Market Growth Prospects
  23. 1.5 Global Acinetobacter Infections Treatment Growth Trends by Region
  24. 1.5.1 Global Acinetobacter Infections Treatment Market Size by Region: 2021 VS 2025 VS 2032
  25. 1.5.2 Acinetobacter Infections Treatment Market Size by Region (2021-2026)
  26. 1.5.3 Acinetobacter Infections Treatment Market Size by Region (2027-2032)
  27. 1.6 Assumptions and Limitations
  28. 1.7 Study Goals and Objectives
  29. 1.8 Years Considered
2 Global Acinetobacter Infections Treatment Market Dynamics
  1. 2.1 Acinetobacter Infections Treatment Industry Trends
  2. 2.2 Acinetobacter Infections Treatment Industry Drivers
  3. 2.3 Acinetobacter Infections Treatment Industry Opportunities and Challenges
  4. 2.4 Acinetobacter Infections Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Acinetobacter Infections Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Acinetobacter Infections Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Acinetobacter Infections Treatment Key Company Head office and Area Served
  4. 3.4 Global Acinetobacter Infections Treatment Company, Product Type & Application
  5. 3.5 Global Acinetobacter Infections Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Acinetobacter Infections Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Acinetobacter Infections Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Acinetobacter Infections Treatment Tier 1, Tier 2, and Tier 3
4 Acinetobacter Infections Treatment Market by Type
  1. 4.1 Global Acinetobacter Infections Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Acinetobacter Infections Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Acinetobacter Infections Treatment Market Size Share by Type (2021-2032)
5 Acinetobacter Infections Treatment Market by Application
  1. 5.1 Global Acinetobacter Infections Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Acinetobacter Infections Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Acinetobacter Infections Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Entasis Therapeutics
  2. 6.1.1 Entasis Therapeutics Company Information
  3. 6.1.2 Entasis Therapeutics Business Overview
  4. 6.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Entasis Therapeutics Acinetobacter Infections Treatment Product Portfolio
  6. 6.1.5 Entasis Therapeutics Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Roche Acinetobacter Infections Treatment Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 Adenium Biotech
  14. 6.3.1 Adenium Biotech Company Information
  15. 6.3.2 Adenium Biotech Business Overview
  16. 6.3.3 Adenium Biotech Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Adenium Biotech Acinetobacter Infections Treatment Product Portfolio
  18. 6.3.5 Adenium Biotech Recent Developments
  19. 6.4 Vaxdyn
  20. 6.4.1 Vaxdyn Company Information
  21. 6.4.2 Vaxdyn Business Overview
  22. 6.4.3 Vaxdyn Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Vaxdyn Acinetobacter Infections Treatment Product Portfolio
  24. 6.4.5 Vaxdyn Recent Developments
  25. 6.5 Hsiri Therapeutics
  26. 6.5.1 Hsiri Therapeutics Company Information
  27. 6.5.2 Hsiri Therapeutics Business Overview
  28. 6.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Hsiri Therapeutics Acinetobacter Infections Treatment Product Portfolio
  30. 6.5.5 Hsiri Therapeutics Recent Developments
  31. 6.6 Aridis Pharmaceuticals
  32. 6.6.1 Aridis Pharmaceuticals Company Information
  33. 6.6.2 Aridis Pharmaceuticals Business Overview
  34. 6.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio
  36. 6.6.5 Aridis Pharmaceuticals Recent Developments
  37. 6.7 LegoChem Biosciences
  38. 6.7.1 LegoChem Biosciences Company Information
  39. 6.7.2 LegoChem Biosciences Business Overview
  40. 6.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 LegoChem Biosciences Acinetobacter Infections Treatment Product Portfolio
  42. 6.7.5 LegoChem Biosciences Recent Developments
  43. 6.8 Atterx Biotherapeutics
  44. 6.8.1 Atterx Biotherapeutics Company Information
  45. 6.8.2 Atterx Biotherapeutics Business Overview
  46. 6.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Atterx Biotherapeutics Acinetobacter Infections Treatment Product Portfolio
  48. 6.8.5 Atterx Biotherapeutics Recent Developments
  49. 6.9 Achaogen
  50. 6.9.1 Achaogen Company Information
  51. 6.9.2 Achaogen Business Overview
  52. 6.9.3 Achaogen Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Achaogen Acinetobacter Infections Treatment Product Portfolio
  54. 6.9.5 Achaogen Recent Developments
  55. 6.10 Peptilogics
  56. 6.10.1 Peptilogics Company Information
  57. 6.10.2 Peptilogics Business Overview
  58. 6.10.3 Peptilogics Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Peptilogics Acinetobacter Infections Treatment Product Portfolio
  60. 6.10.5 Peptilogics Recent Developments
  61. 6.11 Sealife PHARMA
  62. 6.11.1 Sealife PHARMA Company Information
  63. 6.11.2 Sealife PHARMA Business Overview
  64. 6.11.3 Sealife PHARMA Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sealife PHARMA Acinetobacter Infections Treatment Product Portfolio
  66. 6.11.5 Sealife PHARMA Recent Developments
  67. 6.12 Shionogi
  68. 6.12.1 Shionogi Company Information
  69. 6.12.2 Shionogi Business Overview
  70. 6.12.3 Shionogi Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Shionogi Acinetobacter Infections Treatment Product Portfolio
  72. 6.12.5 Shionogi Recent Developments
  73. 6.13 Techulon
  74. 6.13.1 Techulon Company Information
  75. 6.13.2 Techulon Business Overview
  76. 6.13.3 Techulon Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Techulon Acinetobacter Infections Treatment Product Portfolio
  78. 6.13.5 Techulon Recent Developments
  79. 6.14 Tetraphase Pharmaceuticals
  80. 6.14.1 Tetraphase Pharmaceuticals Company Information
  81. 6.14.2 Tetraphase Pharmaceuticals Business Overview
  82. 6.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Portfolio
  84. 6.14.5 Tetraphase Pharmaceuticals Recent Developments
7 North America
  1. 7.1 North America Acinetobacter Infections Treatment Market Size (2021-2032)
  2. 7.2 North America Acinetobacter Infections Treatment Market Size by Type
  3. 7.2.1 North America Acinetobacter Infections Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Acinetobacter Infections Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Acinetobacter Infections Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Acinetobacter Infections Treatment Market Size by Application
  7. 7.3.1 North America Acinetobacter Infections Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Acinetobacter Infections Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Acinetobacter Infections Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Acinetobacter Infections Treatment Market Size by Country
  11. 7.4.1 North America Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Acinetobacter Infections Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Acinetobacter Infections Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Acinetobacter Infections Treatment Market Size (2021-2032)
  2. 8.2 Europe Acinetobacter Infections Treatment Market Size by Type
  3. 8.2.1 Europe Acinetobacter Infections Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Acinetobacter Infections Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Acinetobacter Infections Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Acinetobacter Infections Treatment Market Size by Application
  7. 8.3.1 Europe Acinetobacter Infections Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Acinetobacter Infections Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Acinetobacter Infections Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Acinetobacter Infections Treatment Market Size by Country
  11. 8.4.1 Europe Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Acinetobacter Infections Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Acinetobacter Infections Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Acinetobacter Infections Treatment Market Size (2021-2032)
  2. 9.2 China Acinetobacter Infections Treatment Market Size by Type
  3. 9.2.1 China Acinetobacter Infections Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Acinetobacter Infections Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Acinetobacter Infections Treatment Market Share by Type (2021-2032)
  6. 9.3 China Acinetobacter Infections Treatment Market Size by Application
  7. 9.3.1 China Acinetobacter Infections Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Acinetobacter Infections Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Acinetobacter Infections Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Acinetobacter Infections Treatment Market Size (2021-2032)
  2. 10.2 Asia Acinetobacter Infections Treatment Market Size by Type
  3. 10.2.1 Asia Acinetobacter Infections Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Acinetobacter Infections Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Acinetobacter Infections Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Acinetobacter Infections Treatment Market Size by Application
  7. 10.3.1 Asia Acinetobacter Infections Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Acinetobacter Infections Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Acinetobacter Infections Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Acinetobacter Infections Treatment Market Size by Country
  11. 10.4.1 Asia Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Acinetobacter Infections Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Acinetobacter Infections Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Acinetobacter Infections Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Acinetobacter Infections Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Acinetobacter Infections Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Acinetobacter Infections Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst